Your browser doesn't support javascript.
loading
Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis.
de Andrade, Kelvin C; Frone, Megan N; Wegman-Ostrosky, Talia; Khincha, Payal P; Kim, Jung; Amadou, Amina; Santiago, Karina M; Fortes, Fernanda P; Lemonnier, Nathanaël; Mirabello, Lisa; Stewart, Douglas R; Hainaut, Pierre; Kowalski, Luiz P; Savage, Sharon A; Achatz, Maria I.
Afiliación
  • de Andrade KC; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Frone MN; International Research Center, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Wegman-Ostrosky T; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Khincha PP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Kim J; Division of Research, National Cancer Institute, Mexico City, Mexico.
  • Amadou A; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Santiago KM; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Fortes FP; Institute for Advanced Biosciences, Inserm U 1209 CNRS UMR 5309 Université Grenoble Alpes, Site Santé, Allée des Alpes, La Tronche, France.
  • Lemonnier N; International Research Center, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Mirabello L; International Research Center, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Stewart DR; Institute for Advanced Biosciences, Inserm U 1209 CNRS UMR 5309 Université Grenoble Alpes, Site Santé, Allée des Alpes, La Tronche, France.
  • Hainaut P; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Kowalski LP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland.
  • Savage SA; Institute for Advanced Biosciences, Inserm U 1209 CNRS UMR 5309 Université Grenoble Alpes, Site Santé, Allée des Alpes, La Tronche, France.
  • Achatz MI; Department of Head and Neck Surgery and Otorhinolaryngology, AC Camargo Cancer Center, São Paulo, Brazil.
Hum Mutat ; 40(1): 97-105, 2019 01.
Article en En | MEDLINE | ID: mdl-30352134

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Mutación de Línea Germinal / Bases de Datos Genéticas / Anotación de Secuencia Molecular / Genética de Población Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Hum Mutat Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Mutación de Línea Germinal / Bases de Datos Genéticas / Anotación de Secuencia Molecular / Genética de Población Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Hum Mutat Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article
...